Ethicon introduces absorbable suture in UK:
This article was originally published in Clinica
Ethicon has launched Monocryl, its pliable monofilament absorbable suture, in the UK. The suture has double the initial strength of chromic catgut and equivalent knot security to other absorbables. Unlike catgut, Monocryl has a predictable loss of tensile strength because it is achieved by systematic hydrolysis. The product provides predictable strength retention through the critical 14 days after implantation and is appropriate for gastrointestinal, plastic, gynaecological and obstetric surgeries. Monocryl has been available in the US since 1993.
You may also be interested in...
Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.
We clean out your Martin Luther King Day inbox so you don't have to.
Political worries aside, industry is confidently executing on focused strategies as it welcomes a new decade, even if a lack of deal news at the J.P. Morgan Healthcare Conference didn't excite investors.